Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes
Abstract
AIM: To quantify the effect of weight loss on glycated haemoglobin (HbA1c) at group level, based on data from published weight loss trials in overweight and obese patients with type 2 diabetes (T2D). METHODS: A systematic literature search in MEDLINE, EMBASE and Cochrane CENTRAL (January 1990 through December 2012) was conducted to identify prospective trials of energy-reduced diets, obesity drugs or bariatric surgery in adult, overweight and obese patients with T2D. Based on clinical data with follow-up from 3 to 24 months, a linear model was developed to describe the effect of weight reduction on HbA1c. RESULTS: The literature search identified 58 eligible articles consisting of 124 treatment groups and 17 204 subjects, yielding a total of 250 data points with concurrent mean changes from baseline in weight and HbA1c. The model-based analyses indicated a linear relationship between weight loss and HbA1c reduction, with an estimated mean HbA1c reduction of 0.1 percentage points for each 1 kg of reduced body weight for the overall population. Baseline HbA1c was a significant covariate for the relationship between weight loss and HbA1c: high HbA1c at baseline was associated with a greater reduction in HbA1c for the same degree of weight loss. The collected trial data also indicated weight-loss-dependent reductions in antidiabetic medication. CONCLUSIONS: At group level, weight loss in obese and overweight patients with T2D was consistently accompanied by HbA1c reduction in a dose-dependent manner. The model developed in the present study estimates that for each kg of mean weight loss, there is a mean HbA1c reduction of 0.1 percentage points. HbA1c-lowering is greater in populations with poor glycaemic control than in well controlled populations with the same degree of weight loss. This summary of data from previous trials regarding the effect of weight reduction on HbA1c may be used to support the design and interpretation of future studies that aim to demonstrate the efficacy of weight loss interventions for T2D treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Weight change is known to impact HbA1c values.
“Weight change is known to impact HbA1c values (34).”
Cites
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560 · see citing works
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207 · see citing works
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908 · see citing works
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735 · see citing works
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · see citing works
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164 · see citing works
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791 · see citing works
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522 · see citing works
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · see citing works
Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.148 · Cited by 1,165 · see citing works
Scheen, A. J., Finer, N., Hollander, P. A., Jensen, M. D., & Gaal, L. F. V. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 729 · see citing works
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654 · see citing works
Klein, S., Sheard, N. F., Pi-Sunyer, X., Daly, A., Wylie-Rosett, J., Kulkarni, K., & Clark, N. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2067 · Cited by 540 · see citing works
O'Neil, P. M., Smith, S. R., Weissman, N. J., Fidler, M. C., Sanchez, M., Zhang, J., Raether, B., Anderson, C. M., & Shanahan, W. R. (2012) · Obesity · doi:10.1038/oby.2012.66 · Cited by 528 · see citing works
Westman, E. C., Yancy, W. S., Mavropoulos, J. C., Marquart, M., & McDuffie, J. R. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-36 · Cited by 475 · see citing works
Parker, B., Noakes, M., Luscombe, N., & Clifton, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.425 · Cited by 358 · see citing works
Daousi, C., Casson, I. F., Gill, G. V., MacFarlane, I. A., Wilding, J. P. H., & Pinkney, J. H. (2006) · Postgraduate Medical Journal · doi:10.1136/pmj.2005.039032 · Cited by 351 · see citing works
Dixon, J. B., & O’Brien, P. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.358 · Cited by 319 · see citing works
Kelley, D. E., Bray, G. A., Pi-Sunyer, F. X., Klein, S., Hill, J., Miles, J., & Hollander, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1033 · Cited by 314 · see citing works
Kahleova, H., Matoulek, M., Malinska, H., Oliyarnik, O., Kazdova, L., Neskudla, T., Skoch, A., Hajek, M., Hill, M., Kahle, M., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03209.x · Cited by 312 · see citing works
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
Miles, J. M., Leiter, L., Hollander, P., Wadden, T., Anderson, J. W., Doyle, M., Foreyt, J., Aronne, L., & Klein, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1123 · Cited by 286 · see citing works
Davis, N. J., Tomuta, N., Schechter, C., Isasi, C. R., Segal-Isaacson, C. J., Stein, D., Zonszein, J., & Wylie-Rosett, J. (2009) · Diabetes Care · doi:10.2337/dc08-2108 · Cited by 256 · see citing works
Fujioka, K., Seaton, T. B., Rowe, E., Jelinek, C. A., Raskin, P., Lebovitz, H. E., Weinstein, S. P., & Group, T. S. C. S. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00081.x · Cited by 244 · see citing works
Wycherley, T. P., Noakes, M., Clifton, P. M., Cleanthous, X., Keogh, J. B., & Brinkworth, G. D. (2010) · Diabetes Care · doi:10.2337/dc09-1974 · Cited by 240 · see citing works
Wing, R. R., Blair, E., Marcus, M., Epstein, L. H., & Harvey, J. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90302-6 · Cited by 228 · see citing works
Larsen, R. N., Mann, N. J., Maclean, E., & Shaw, J. E. (2011) · Diabetologia · doi:10.1007/s00125-010-2027-y · Cited by 197 · see citing works
Miller, C. K., Kristeller, J. L., Headings, A., Nagaraja, H., & Miser, W. F. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.07.036 · Cited by 179 · see citing works
Nannipieri, M., Mari, A., Anselmino, M., Baldi, S., Barsotti, E., Guarino, D., Camastra, S., Bellini, R., Berta, R. D., & Ferrannini, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0446 · Cited by 176 · see citing works
Brinkworth, G. D., Noakes, M., Parker, B., Foster, P., & Clifton, P. M. (2004) · Diabetologia · doi:10.1007/s00125-004-1511-7 · Cited by 175 · see citing works
Lee, W., Ser, K., Chong, K., Lee, Y.-C., Chen, S., Tsou, J.-J., Chen, J., & Chen, C. (2009) · Surgery · doi:10.1016/j.surg.2009.10.059 · Cited by 175 · see citing works
Finer, N., Bloom, S. R., Frost, G. S., Banks, L. M., & Griffiths, J. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00071.x · Cited by 171 · see citing works
Kelley, D. E., Kuller, L. H., McKolanis, T. M., Harper, P. H., Mancino, J., & Kalhan, S. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.33 · Cited by 167 · see citing works
McNulty, S., Ur, E., & Williams, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.125 · Cited by 167 · see citing works
Hanefeld, M., & Sachse, G. (2002) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00237.x · Cited by 151 · see citing works
Iqbal, N., Vetter, M. L., Moore, R. H., Chittams, J. L., Dalton‐Bakes, C. V., Dowd, M., Williams‐Smith, C., Cardillo, S., & Wadden, T. A. (2010) · Obesity · doi:10.1038/oby.2009.460 · Cited by 144 · see citing works
Li, Z., Hong, K. M., Saltsman, P., DeShields, S., Bellman, M., Thames, G., Liu, Y., Wang, H., Elashoff, R. M., & Heber, D. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602089 · Cited by 143 · see citing works
SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients
Rosenstock, J., Hollander, P. A., Chevalier, S., Iranmanesh, A., & for the SERENADE Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0386 · Cited by 121 · see citing works
Berne, C., & the Orlistat Swedish Type 2 diabetes Study Group (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01474.x · Cited by 112 · see citing works
Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes
Vettor, R., Serra, R., Fabris, R., Pagano, C., & Federspil, G. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.942 · Cited by 105 · see citing works
Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m 2
Li, Q., Chen, L., Yang, Z., Ye, Z., Huang, Y., He, M., Zhang, S., Feng, X., Gong, W., Zhang, Z., et al. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01524.x · Cited by 102 · see citing works
Effects of Sibutramine in Obese Female Subjects With Type 2 Diabetes and Poor Blood Glucose Control
Gökçel, A., Karakose, H., Ertörer, M. E., Tanaci, N., Tütüncü, N. B., & Guvener, N. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1957 · Cited by 100 · see citing works
Terranova, C. O., Brakenridge, C. L., Lawler, S. P., Eakin, E. G., & Reeves, M. M. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12430 · Cited by 94 · see citing works
Kopelman, P. G., de Groot, H. G., Rissanen, A., Rössner, S., Toubro, S., Palmer, R., Hallam, R., Bryson, A. L., & Hickling, R. I. (2009) · Obesity · doi:10.1038/oby.2009.155 · Cited by 93 · see citing works
Effects of Biliopanceratic Diversion on Type 2 Diabetes in Patients With BMI 25 to 35
Scopinaro, N., Adami, G., Papadia, F. S., Camerini, G. B., Carlini, F., Fried, M., Briatore, L., D’Alessandro, G., Andraghetti, G., & Cordera, R. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e318203ae44 · Cited by 91 · see citing works
Liquid Meal Replacements and Glycemic Control in Obese Type 2 Diabetes Patients
Yip, I., Go, V. L. W., DeShields, S., Saltsman, P., Bellman, M., Thames, G., Murray, S. P. L., Wang, H., Elashoff, R. M., & Heber, D. (2001) · Obesity Research · doi:10.1038/oby.2001.140 · Cited by 86 · see citing works
Rosenstock, J., Hollander, P., Gadde, K. M., Sun, X., Strauss, R., Leung, A., & for the OBD-202 Study Group (2007) · Diabetes Care · doi:10.2337/dc06-2001 · Cited by 85 · see citing works
Topiramate in the treatment of obese subjects with drug‐naive type 2 diabetes
Stenlöf, K., Rössner, S. M., Vercruysse, F., Kumar, A., Fitchet, M., Sjöström, L., & Study Group (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00618.x · Cited by 78 · see citing works
One-Year Outcome of a Combination of Weight Loss Therapies for Subjects With Type 2 Diabetes
Redmon, J. B., Raatz, S. K., Reck, K. P., Swanson, J. E., Kwong, C. A., Fan, Q., Thomas, W. T. B., & Bantle, J. P. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2505 · Cited by 77 · see citing works
Fabricatore, A. N., Wadden, T. A., Ebbeling, C. B., Thomas, J. G., Stallings, V. A., Schwartz, S. S., & Ludwig, D. S. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.12.016 · Cited by 75 · see citing works
for the OBDM-002 Study Group, Toplak, H., Hamann, A., Moore, R., Masson, E., Górska, M., Vercruysse, F., Sun, X., & Fitchet, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803382 · Cited by 74 · see citing works
Halpern, A., Mancini, M. C., Suplicy, H., Zanella, M. T., Repetto, G., Gross, J. L., Jadzinsky, M. N., Barranco, J. G., Aschner, P. J., Ramirez, L., et al. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00262.x · Cited by 71 · see citing works
Serrano‐Ríos, M., Melchionda, N., & Carretero, E. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00655.x · Cited by 69 · see citing works
Luley, C. H., Blaik, A., Reschke, K., Klose, S., & Westphal, S. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.020 · Cited by 62 · see citing works
Aldekhail, N. M., Logue, J., McLoone, P., & Morrison, D. S. (2015) · Obesity Reviews · doi:10.1111/obr.12318 · Cited by 61 · see citing works
Kipnes, M. S., Hollander, P. A., Fujioka, K., Gantz, I., Seck, T. L., Erondu, N., Shentu, Y., Lu, K., Suryawanshi, S., Chou, M. Z., et al. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01188.x · Cited by 56 · see citing works
Derosa, G., Cicero, A. F. G., D’Angelo, A., Fogari, E., & Maffioli, P. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01280.x · Cited by 53 · see citing works
Effects of orlistat on obesity‐related diseases – a six‐month randomized trial
Guy-grand, B., Drouin, P., Eschwège, É., Gin, H., Joubert, J., & Valensi, P. E. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00359.x · Cited by 44 · see citing works
Shah, P. S., Todkar, J. S., & Shah, S. S. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.06.007 · Cited by 43 · see citing works
Anderson, J. W., Brinkman-Kaplan, V., Hamilton, C., Logan, J. E. B., Collins, R. W., & Gustafson, N. (1994) · Diabetes Care · doi:10.2337/diacare.17.6.602 · Cited by 42 · see citing works
Metabolic Laparoscopic Gastric Bypass for Obese Patients with Type 2 Diabetes
Nora, M. C., Guimarães, M., Almeida, R., Martins, P., Gonçalves, G., Freire, M. J., Ferreira, T., Freitas, C., & Monteiro, M. P. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0418-x · Cited by 39 · see citing works
Shi, Y. ‐., Pan, C. ‐., Hill, J., & Gao, Y. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01723.x · Cited by 38 · see citing works
Aronne, L. J., Finer, N., Hollander, P. A., England, R. D., Klioze, S. S., Chew, R. D., Fountaine, R. J., Powell, C. M., & Obourn, J. D. (2011) · Obesity · doi:10.1038/oby.2010.352 · Cited by 37 · see citing works
Sánchez‐Reyes, L., Fanghänel, G., YAMAMOTO, J., MARTINEZRIVAS, L., Campos-Franco, E., & Berber, A. C. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.09.017 · Cited by 35 · see citing works
Hung, Y. ‐., Chen, Y., Pei, D., Kuo, S. ‐., Hsieh, C. ‐., Wu, L. ‐., He, C., Lee, C.-H., Fan, S. C., & Sheu, W. H. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01569.x · Cited by 31 · see citing works
Effects of Obesity Surgery on Type 2 Diabetes Mellitus Asian Patients
Lee, W., Chong, K., Lee, Y., Ser, K., Chen, S., Chen, J., Peng, W., & Chen, C. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0115-2 · Cited by 27 · see citing works
Cocco, G., Pandolfi, S., & Rousson, V. (2005) · Heart Drug · doi:10.1159/000083662 · Cited by 14 · see citing works
Sibutramine in the treatment of obesity in type 2 diabetic patients and in nondiabetic subjects
Tankova, T. I., Dakovska, G., Lazarova, M., Dakovska, L. N., Кirilov, G., & Koev, D. (2004) · Acta Diabetologica · doi:10.1007/s00592-004-0158-7 · Cited by 14 · see citing works
Derosa, G., Maffioli, P., Ferrari, I., Palumbo, I., Randazzo, S., D’Angelo, A., & Cicero, A. F. G. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01217.x · Cited by 13 · see citing works
Esposito, K., Maiorino, M. I., Ciotola, M., Di Palo, C., Scognamiglio, P., Gicchino, M., Petrizzo, M., Saccomanno, F., Beneduce, F., Ceriello, A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00004 · Cited by 13 · see citing works
Wang, T.-F., Pei, D., Jc, L., Tsai, W.-C., Tsai, C.-C., Yao, C.-Y., Chang, E.-T., Mc, H., Su, K., & Kuo, S.-W. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00568.x · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660 · see citing works
Frias, J. P., Deenadayalan, S., Erichsen, L., Knop, F. K., Lingvay, I., Macura, S., Mathieu, C., Pedersen, S. D., & Davies, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01163-7 · Cited by 334 · see citing works
van Baar, A. C. G., Holleman, F., Crenier, L., Haidry, R., Magee, C., Hopkins, D., Rodriguez Grunert, L., Galvao Neto, M., Vignolo, P., Hayee, B., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318349 · Cited by 201 · see citing works
Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199 · see citing works
Cardiometabolic Benefits of Intermittent Fasting
Varady, K. A., Cienfuegos, S., Ezpeleta, M., & Gabel, K. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-052020-041327 · Cited by 186 · see citing works
Gardner, C. D., Landry, M. J., Perelman, D., Petlura, C., Durand, L. R., Aronica, L., Crimarco, A., Cunanan, K. M., Chang, A., Dant, C. C., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac154 · Cited by 151 · see citing works
Alba, M., Yee, J., Frustaci, M. E., Samtani, M. N., & Fleck, P. (2021) · Clinical Obesity · doi:10.1111/cob.12432 · Cited by 100 · see citing works
Tarumi, S., Takeuchi, W., Chalkidis, G., Rodriguez-Loya, S., Kuwata, J., Flynn, M., Turner, K. M., Sakaguchi, F. H., Weir, C., Kramer, H., et al. (2021) · Methods of Information in Medicine · doi:10.1055/s-0041-1728757 · Cited by 84 · see citing works
The limits and challenges of antiobesity pharmacotherapy
Gadde, K. M., & Atkins, K. D. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1748599 · Cited by 65 · see citing works
Di Prospero, N. A., Yee, J., Frustaci, M. E., Samtani, M. N., Alba, M., & Fleck, P. (2021) · Clinical Obesity · doi:10.1111/cob.12433 · Cited by 60 · see citing works
Pratley, R. E., Kang, J., Trautmann, M. E., Hompesch, M., Han, O., Stewart, J., Sorli, C. H., Jacob, S., & Yoon, K. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13824 · Cited by 49 · see citing works
Xia, S.-F., Maitiniyazi, G., Chen, Y., Wu, X.-Y., Zhang, Y., Zhang, X.-Y., Li, Z.-Y., Liu, Y., Qiu, Y.-Y., & Wang, J. (2022) · JMIR mhealth and uhealth · doi:10.2196/30571 · Cited by 40 · see citing works
Kim, M. T., Kim, K. B., Nguyen, T. H., Ko, J., Zabora, J., Jacobs, E., & Levine, D. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2018.10.021 · Cited by 28 · see citing works
Kusinski, L. C., Jones, D., Atta, N., Turner, E., Smith, S., Oude Griep, L. M., Rennie, K., De Lucia Rolfe, E., Sharp, S. J., Farewell, V., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03356-1 · Cited by 30 · see citing works
Weight loss and side-effects of liraglutide and lixisenatide in obesity and type 2 diabetes mellitus
Lee, J., Kim, R., Kim, M.-H., Lee, S.-H., Cho, J.-H., Lee, J. M., Jang, S.-A., & Kim, H.-S. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.07.006 · Cited by 20 · see citing works
Examining the evidence for weight management in individuals with type 2 diabetes
Garvey, W. T., Umpierrez, G. E., Dunn, J. P., Kwan, A. Y. M., Varnado, O. J., Konig, M., & Levine, J. A. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14764 · Cited by 18 · see citing works
Clinical potential of fasting in type 1 diabetes
Varady, K. A., Runchey, M.-C., Reutrakul, S., Vidmar, A. P., & Chow, L. S. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.01.007 · Cited by 12 · see citing works
- Authors
- Gummesson, A., Nyman, E., Knutsson, M., & Karpefors, M.
- Affiliations
- Sahlgrenska University Hospital (SE)
- AstraZeneca (Sweden) (SE)
- Corresponding author
- Karpefors, Martin
- Venue
- Diabetes Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2017-05-22
- Volume
- 19
- Issue
- 9
- Pages
- 1295-1305
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2605914979
- Cited by
- 162
- References
- 71
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 19 · 2023: 20 · 2022: 24 · 2021: 35 · 2020: 20 · 2019: 16 · 2018: 4 · 2017: 2
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Obesity and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- AstraZeneca
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- weight loss, HbA1c, type 2 diabetes, obesity, overweight, hypocaloric diet, obesity drugs, bariatric surgery, dose-response relationship, baseline HbA1c, antidiabetic medication reduction, glycemic control
- MeSH terms
- Combined Modality Therapy, Diabetes Mellitus, Type 2, Diet, Reducing, Glycated Hemoglobin, Humans, Hyperglycemia, Middle Aged, Obesity, Obesity, Morbid, Weight Loss, Exercise, Randomized Controlled Trials as Topic, Anti-Obesity Agents, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
